Capecitabine, DNA/RNA Synthesis Inhibitor

Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.

Frontiers Co-delivery of Cisplatin(IV) and Capecitabine as an Effective and Non-toxic Cancer Treatment

Cells, Free Full-Text

is a tumor-selective fluoropyrimidine carbamate, which achieves higher intratumoral 5-FU level with lower toxicity than 5-FU.

Capecitabine

Molecules, Free Full-Text

Thymidine Monophosphate - an overview

Defueling the cancer: ATP synthase as an emerging target in cancer therapy: Molecular Therapy - Oncolytics

Drug combination and repurposing for cancer therapy: the example of breast cancer

TAS1553, a small molecule subunit interaction inhibitor of ribonucleotide reductase, exhibits antitumor activity by causing DNA replication stress

Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer - Clifford - 2018 - BJS (British Journal of Surgery) - Wiley Online Library

THOC5 complexes with DDX5, DDX17, and CDK12 to regulate R loop structures and transcription elongation rate